These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6968579)

  • 1. Protease inhibitor profiles in urticaria and angio-oedema.
    Eftekhari N; Ward AM; Allen R; Greaves MW
    Br J Dermatol; 1980 Jul; 103(1):33-9. PubMed ID: 6968579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma protease inhibitor and anaphylatoxin inactivator levels in chronic urticaria/angioedema and in patients experiencing anaphylactoid reactions to radiographic contrast media.
    Mathews KP; Pan PM; Amendola MA; Lewis FH
    Int Arch Allergy Appl Immunol; 1986; 79(2):220-3. PubMed ID: 3943918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease inhibitors in plasma of patients with chronic urticaria.
    Doeglas HM; Bleumink E
    Arch Dermatol; 1975 Aug; 111(8):979-85. PubMed ID: 60915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 1-antitrypsin deficiency and PI typing in patients with chronic urticaria.
    Doeglas HM; Klasen EC; Bleumink E
    Br J Dermatol; 1985 Apr; 112(4):381-5. PubMed ID: 3873251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease inhibitor deficiencies in patients with angio-oedema.
    Bleumink E; Doeglas HM
    Clin Exp Dermatol; 1986 May; 11(3):274-83. PubMed ID: 3488855
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterozygous alpha 1-antichymotrypsin deficiency may be associated with cold urticaria.
    Lindmark B; Wallengren J
    Allergy; 1992 Oct; 47(5):456-8. PubMed ID: 1485647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitor profiles in urticaria and angio-oedema [proceedings].
    Eftekhari N; Ward AM; Allen R; Greaves MW
    Br J Dermatol; 1979 Jul; 101 Suppl 17():20-1. PubMed ID: 475886
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholinergic urticaria with associated angio-oedema.
    Lawrence CM; Jorizzo JL; Kobza-Black A; Coutts A; Greaves MW
    Br J Dermatol; 1981 Nov; 105(5):543-50. PubMed ID: 7295570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of insertion/deletion polymorphism of the angiotensin-converting enzyme gene with angio-oedema accompanying chronic urticaria but not chronic urticaria without angio-oedema or the autologous serum skin test response.
    Akcali C; Ozkur M; Erbagci Z; Benlier N; Aynacioglu AS
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):83-6. PubMed ID: 18181977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Classification of urticaria and genetic angioedema].
    Venencie PY
    Allerg Immunol (Paris); 1993 Oct; 25(8):327-9. PubMed ID: 8267842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1-bypass complement-activation pathway in patients with chronic urticaria and angio-oedema.
    Ballow M; Ward GW; Gershwin ME; Day NK
    Lancet; 1975 Aug; 2(7928):248-50. PubMed ID: 49798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angio-oedema induced by oestrogen contraceptives is mediated by bradykinin and is frequently associated with urticaria.
    Giard C; Nicolie B; Drouet M; Lefebvre-Lacoeuille C; Le Sellin J; Bonneau JC; Maillard H; Rénier G; Cichon S; Ponard D; Drouet C; Martin L
    Dermatology; 2012; 225(1):62-9. PubMed ID: 22922353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum alpha 1-protease inhibitor levels in patients with chronic idiopathic urticaria.
    Imai S
    Acta Derm Venereol; 1993 Feb; 73(1):10-1. PubMed ID: 8095742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urticaria, angioedema and complement abnormalities].
    Doutre MS
    Allerg Immunol (Paris); 1993 Oct; 25(8):339-40. PubMed ID: 8267845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma protease inhibitors in alpha 1-antitrypsin-deficient children.
    Sveger T
    Pediatr Res; 1985 Aug; 19(8):834-5. PubMed ID: 3875830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior of esterase inhibitor C1 in patients with urticaria due to aspirin hypersensitivity].
    Grzelewska-Rzymowska I; Szmidt M; Rozniecki J; Ruta U
    Pneumonol Alergol Pol; 1993; 61(7-8):352-6. PubMed ID: 8401339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and aetiological aspects in urticaria and angio-oedema.
    Nettis E; Pannofino A; D'Aprile C; Ferrannini A; Tursi A
    Br J Dermatol; 2003 Mar; 148(3):501-6. PubMed ID: 12653742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria.
    Wong E; Eftekhari N; Greaves MW; Ward AM
    Br J Dermatol; 1987 Apr; 116(4):553-6. PubMed ID: 3555598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angio-oedema in dentistry: management of two cases using C1 esterase inhibitor.
    Socker M; Boyle C; Burke M
    Dent Update; 2005; 32(6):350-2, 354. PubMed ID: 16117356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RCPCH care pathway for children with urticaria, angio-oedema or mastocytosis: an evidence and consensus based national approach.
    Leech S; Grattan C; Lloyd K; Deacock S; Williams L; Langford A; Warner J;
    Arch Dis Child; 2011 Nov; 96 Suppl 2():i34-7. PubMed ID: 22053065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.